MW 390.6 Da, Purity >99%. Novel HDAC inhibitor (IC50 values are 32, 48 and 41 nM at HDAC4, HDAC1 and HDAC6, respectively). Induces apoptosis and inhibits cell growth of various malignant cells and tumor cells lines (EC50 = 3.8 μM). Also reactivates latent HIV-1 gene expression.
Images
Key facts
- CAS number
- 848354-66-5
- Purity
- > 99%
- Form
- Solid
- Molecular weight
- 390.6 Da
- Molecular formula
- C20H26N2O2S2
- PubChem identifier
- 11395181
- Nature
- Synthetic
Target data
Alternative names
AHO3, BDMR, CPBHM, DKFZp686H12203, EC 3.5.1.98, FLJ16239, GON 10, HA6116, HD 4, HD 6, HD1, HDAC A, HDAC1_HUMAN, HDAC4_HUMAN, HDAC6_HUMAN, Histone Deacetylase A, Histone deacetylase 1, Histone deacetylase 4, Histone deacetylase 6, Histone deacetylase 6 (HD6), JM 21, KIAA0288, KIAA0901, OTTHUMP00000032398, OTTHUMP00000197663, PPP1R90, Protein phosphatase 1 regulatory subunit 90, RPD 3, RPD3L1, Reduced potassium dependency yeast homolog like 1
Recommended products
MW 390.6 Da, Purity >99%. Novel HDAC inhibitor (IC50 values are 32, 48 and 41 nM at HDAC4, HDAC1 and HDAC6, respectively). Induces apoptosis and inhibits cell growth of various malignant cells and tumor cells lines (EC50 = 3.8 μM). Also reactivates latent HIV-1 gene expression.
Key facts
- CAS number
- 848354-66-5
- Purity
- > 99%
- Form
- Solid
- Molecular weight
- 390.6 Da
- Molecular formula
- C20H26N2O2S2
- PubChem identifier
- 11395181
- Nature
- Synthetic
- Solubility
Soluble in DMSO to 100 mM.
Soluble in ethanol to 25 mM.
- Biochemical name
- Ptach
- Biological description
Novel HDAC inhibitor (IC50 values are 32, 48 and 41 nM at HDAC4, HDAC1 and HDAC6, respectively). Induces apoptosis and inhibits cell growth of various malignant cells and tumor cells lines (EC50 = 3.8 μM). Also reactivates latent HIV-1 gene expression.
- Canonical SMILES
- CC(C)C(=O)SCCCCCCC(=O)NC1=NC(=CS1)C2=CC=CC=C2
- InChI
- InChI=1S/C20H26N2O2S2/c1-15(2)19(24)25-13-9-4-3-8-12-18(23)22-20-21-17(14-26-20)16-10-6-5-7-11-16/h5-7,10-11,14-15H,3-4,8-9,12-13H2,1-2H3,(H,21,22,23)
- InChIKey
- MDYDGUOQFUQOGE-UHFFFAOYSA-N
- IUPAC name
- S-[7-oxo-7-[(4-phenyl-1,3-thiazol-2-yl)amino]heptyl] 2-methylpropanethioate
Storage
- Shipped at conditions
- Ambient - Can Ship with Ice
- Appropriate short-term storage conditions
- +4°C
- Appropriate long-term storage conditions
- +4°C
- Storage information
- The product can be stored for up to 12 months
Supplementary info
- This supplementary information is collated from multiple sources and compiled automatically.
- Activity summary
HDAC1 HDAC4 and HDAC6 are histone deacetylases enzymes involved in removing acetyl groups from lysine residues on histone proteins. This activity influences chromatin structure and gene expression by transcription repression. HDAC1 also known as RPD3L1 has a molecular weight of approximately 55 kDa whereas HDAC4 and HDAC6 are larger around 110 kDa and 131 kDa respectively. HDAC1 and HDAC4 are predominantly in the nucleus while HDAC6 mainly localizes in the cytoplasm. The expression of these proteins can be tissue-specific with significant presence in heart pancreas and brain.
- Biological function summary
These HDAC proteins play critical roles in regulating cellular processes such as cell cycle apoptosis and differentiation. HDAC1 is a component of several multiprotein complexes including the Sin3 and NuRD complexes which target chromatin for modulating gene expression. HDAC4 is involved in transcriptional repression associated with muscle and neuronal development. HDAC6 regulates cytoskeleton dynamics primarily through the deacetylation of tubulin. These functions indicate the diverse roles that HDACs can have at cellular level.
- Pathways
HDACs are integral to significant regulatory pathways like cell cycle control and the p53 signaling pathway. HDAC1 interacts with the retinoblastoma protein contributing to cell cycle regulation and tumor suppression. HDAC4 engages in the calcineurin/NFAT pathway relevant for neuronal survival and plasticity. HDAC6 participates in the heat shock protein 90 (HSP90) pathway which is important for the degradation of misfolded proteins thereby interacting with cochaperones and other proteins like tau.
- Associated diseases and disorders
Irregular HDAC activity links to various cancers and neurodegenerative diseases. Overexpression of HDAC1 and HDAC4 associates with certain cancers by altering gene expression conducive to oncogenesis. Meanwhile HDAC6 has connections to neurodegenerative conditions like Alzheimer's disease where it interacts with tau protein contributing to toxic aggregation in neurons. Drugs targeting these HDACs known as HDAC inhibitors represent a therapeutic strategy in treating these conditions leveraging their mechanistic pathways to restore normal cellular function.
Product promise
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
1 product image
Chemical Structure - NCH 51, HDAC inhibitor (ab120949)
2D chemical structure image of ab120949, NCH 51, HDAC inhibitor
Downloads
Product protocols
- Visit the general protocols
- Visit troubleshooting
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com